Latest News

Kalbe Holds HJ Learning Forum Clinic Management in the JKN Area

Kalbe Holds HJ Learning Forum Clinic  Management in the JKN Area

Press Release No. 017/KFCP-DIR/PR/V/18

Makassar, 6 May 2018 – PT Hexpharm Jaya (HJ), a subsidiary of PT Kalbe Farma Tbk (Kalbe) holds the HJ Learning Forum (HJLF) with the theme of “Clinic Management Talk”. The event, held at Hotel Grand Clarion, was attended by more than 150 General Practitioners and Specialists from South Sulawesi. The educational event was opened by Dr. Muhammad Ichsan Mustari, the Chairman of the Indonesian Physicians' Association of South Sulawesi, and Bonny M. Anom, Marketing Manager of PT Hexpharm Jaya. In HJ Learning Forum, Dr. Muhammad Ichsan Mustari, is one of the main speakers who discussed the how-to's of good Clinic and Hospital management in JKN era. Other speakers are dr. drg. Unting Patri Wicaksono Pribadi, Chairman of the Social Health Security Administering Body (BPJS) of Makassar Branch who will present the development and challenges for BPJS in the future.

“HJ Learning Forum is held with the purpose so that Physicians can understand clinic management, specifically premier clinics in order to be able to support the government's JKN program," said Bonny M. Anom, Marketing Manager of PT Hexpharm Jaya. “This event is a form of Hexpharm Jaya's commitment in achieving a healthier Indonesia in accordance with Hexpharm Jaya's mission," Bonny continued.”

The primary care that developed in such speed is in line with the existence of the Government's program. Law No. 24 Year 2011 concerning Indonesian Citizen and foreign nationals who have been residing in Indonesia at the minimum of six months shall be members of BPJS. Thus by year 2019, all Indonesian citizen must have BPJS, and therefore the Level 1 Health Facilities are needed in line with the increase of number of the BPJS holders. What should come to attention, because clinics as Level 1 Health Facility, is the availability of facility and infrastructure that is practical, fast, and qualified.

“The JKN Program have been getting quite a positive response from the public, which could be seen from the increase of membership that is largely filled by employees of the private sectors," said Dr. Muhammad Ichsan Mustari, the Chairman of the Indonesian Physicians' Association of South Sulawesi. “Therefore the pattern of clinical services that provided help from the early hours of the days to night (24 hours) will be the future options for BPJS participants. However, the physicians should be given clinic management abilities in order to run the management of the clinic Physicians have been trained to handle clinical cases, but not to manage clinics organizationally. This is a challenge for physicians to be successful in the JKN era," Dr. Muhammad Ichsan Mustari.

“The JKN program that has entered its fourth year already has a participant of more than 175 million people. With the increase of the participants of the BPJS program, it hopes to increase the quality of health services into an even more commendable one. Therefore, HJ Learning Forum is expected to be able to support the increase of quality of clinics in Indonesia,” Bonny M. Anom added.

HJLF has been consistently held since last year in six cities, and for this year, the HJLF will take place at eight cities: Banjarmasin, Makassar, Bandung, Surabaya, Pekanbaru, Medan, Yogyakarta and Lampung. The forum is expected to become a means of meeting and sharing of knowledge and experience on clinics and medical knowledge.

PT Hexpharm Jaya at a glance
PT. Hexpharm Jaya Laboratories, established in 1971, specifically operates in the fields of development, production, and marketing of generic medications. PT Hexpharm Jaya Laboratories is committed to put forth quality of the medications it produces, to guarantee their effectiveness, stability, and safety.

PT. Hexpharm Jaya Laboratories, a subsidiary of PT. Kalbe Farma Tbk, is included in the list of 20 largest (ethical) pharmaceutical companies in Indonesia, and included among the 3 largest generic pharmaceutical companies in Indonesia.

Kalbe at a glance
PT Kalbe Farma Tbk (“Kalbe”) was established in 1966 and is one of the biggest public pharmaceutical companies in Southeast Asia. Kalbe has four main divisions that handle reliable and varied brand portfolio; prescription medicines (Cefspan, Brainact, Broadced, etc); over-the-counter medication division (Woods, Promag, Mixagrip, Komix, Fatigon, etc); health drinks (Hydro Coco, Extra Joss, Nitros); nutrition division (ChilKid, Prenagen, Diabetasol, etc); and distribution division. Kalbe currently has more than 35 subsidiaries, 14 production facilities with international standard, and employs more than 17,000 employees dispersed across more than 72 branches throughout Indonesia. From 1991, Kalbe is listed at Indonesia Stock Exchange (IDX: KLBF).

--oOo--


Print
686 Rate this article:
No rating

Please login or register to post comments.

Name:
Email:
Subject:
Message:
x